Merck & Co Inc (MRK)

MRK (NYSE:Drugs)
$61.45
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | MRK Avg Daily Volume: 10,519,300
Last Update: 01/28/15 - 4:00 PM EST
Volume: 0
YTD Performance: 8.21%
Open: $0.00
Previous Close: $61.45
52 Week Range: $51.78 - $63.62
Oustanding Shares: 2,850,873,371
Market Cap: 178,350,638,090
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.00 2.00 2.00
Latest Dividend: 0.45
Latest Dividend Yield: 2.88%
Dividend Ex-Date: 12/11/14
Price Earnings Ratio: 34.00
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
34.00 34.30 25.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.03% 16.23% 59.53%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.80 -0.04 -0.01
Net Income -28.30 3.60 0.65
EPS -26.70 4.32 0.74
Earnings for MRK:
EBITDA 14.65B
Revenue 44.03B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.85 $0.78 $3.48 $3.54
Number of Analysts 8 2 12 12
High Estimate $0.89 $0.79 $3.50 $3.70
Low Estimate $0.81 $0.76 $3.46 $3.38
Prior Year $0.88 $0.88 $3.49 $3.48
Growth Rate (Year over Year) -2.98% -11.93% -0.17% 1.72%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jan 15, 2015 | 3:40 PM EST

Use the overall weakness to pick up the America First stocks.

By

Jim Cramer

 | Jan 12, 2015 | 11:19 AM EST

Low P/E multiples just aren't any protection.

By

Christopher Versace

 | Jan 12, 2015 | 9:59 AM EST

Watch the share count when looking at earnings.

By

David Katz

 | Jan 6, 2015 | 9:00 AM EST

Try these stocks for dividend income instead.

By

Brian Sozzi

 | Jan 6, 2015 | 9:00 AM EST

Corporate fundamentals begin to matter. 

By

Jim Cramer

 | Jan 5, 2015 | 10:00 AM EST

The next 10 Dow components in my analysis.

bullishMerck upgraded at Bernstein

Jan 5, 2015 | 8:19 AM EST

MRK was upgraded from Market Perform to Outperform, Bernstein said. $68 price target. Keytruda could be launched up to a year earlier than expected. 

By

David Katz

 | Jan 2, 2015 | 9:00 AM EST

Every dog has its day.

By

Jim Cramer

 | Dec 22, 2014 | 2:51 PM EST

And stop chasing stocks that won't let you in.

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

Investors in emerging markets are bullish, ...

Kulicke & Soffa(+7%)is in full breakout mode today. The stock opened with an ups...
Seemed as if comments related to inflation were a table setter in pushing out the first ra...
While many are concerned about a negative reaction if the Fed doesn't hint at pushing out ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.